171 related articles for article (PubMed ID: 1483999)
1. Intravenous immunoglobulin therapy of immune thrombocytopenia.
Mehta JB; Singhal SB; Mehta BC
J Assoc Physicians India; 1992 May; 40(5):340-2. PubMed ID: 1483999
[TBL] [Abstract][Full Text] [Related]
2. Outcome of children with idiopathic thrombocytopenic purpura, based on original material.
Zawitkowska-Klaczyńska J; Nurzyńska-Flak J; Kattski K; Kowalczyk JR
Ann Univ Mariae Curie Sklodowska Med; 2004; 59(2):194-7. PubMed ID: 16146076
[TBL] [Abstract][Full Text] [Related]
3. Overview of 321 patients with idiopathic thrombocytopenic purpura. Retrospective analysis of the clinical features and response to therapy.
Pamuk GE; Pamuk ON; Başlar Z; Ongören S; Soysal T; Ferhanoğlu B; Aydin Y; Ulkü B; Aktuğlu G; Akman N
Ann Hematol; 2002 Aug; 81(8):436-40. PubMed ID: 12224000
[TBL] [Abstract][Full Text] [Related]
4. [Treatment of idiopathic thrombocytopenic purpura in adults: efficacy of domestic intravenous immunoglobulin in immune thrombocytopenia].
Pugina SA; Evdokimova NM; Rastorguev GG; Samoĭlova OS; Sorokina IV; Sidnev GV; Vasil'ev DM; Anastasiev VV; Milovidova OV; Molodovskaia EV; Borovkov NN
Ter Arkh; 1999; 71(8):50-4. PubMed ID: 10515038
[TBL] [Abstract][Full Text] [Related]
5. Rituximab chimeric anti-CD20 monoclonal antibody treatment for adult refractory idiopathic thrombocytopenic purpura.
Braendstrup P; Bjerrum OW; Nielsen OJ; Jensen BA; Clausen NT; Hansen PB; Andersen I; Schmidt K; Andersen TM; Peterslund NA; Birgens HS; Plesner T; Pedersen BB; Hasselbalch HC
Am J Hematol; 2005 Apr; 78(4):275-80. PubMed ID: 15795920
[TBL] [Abstract][Full Text] [Related]
6. Efficacy and response to intravenous anti-D immunoglobulin in chronic idiopathic thrombocytopenic purpura.
Ramadan KM; El-Agnaf M
Clin Lab Haematol; 2005 Aug; 27(4):267-9. PubMed ID: 16048495
[TBL] [Abstract][Full Text] [Related]
7. [Splenectomy in adult patients with idiopathic thrombocytopenic purpura after intravenous immunoglobulin treatment].
Nowak T; Kucharski W; Scharf R
Acta Haematol Pol; 1994; 25(1):31-5. PubMed ID: 8209611
[TBL] [Abstract][Full Text] [Related]
8. Efficacy and safety of splenectomy in immune thrombocytopenic purpura: long-term results of 402 cases.
Vianelli N; Galli M; de Vivo A; Intermesoli T; Giannini B; Mazzucconi MG; Barbui T; Tura S; Baccaranion M;
Haematologica; 2005 Jan; 90(1):72-7. PubMed ID: 15642672
[TBL] [Abstract][Full Text] [Related]
9. Anti-beta2-glycoprotein I in childhood immune thrombocytopenic purpura.
El-Bostany EA; El-Ghoroury EA; El-Ghafar EA
Blood Coagul Fibrinolysis; 2008 Jan; 19(1):26-31. PubMed ID: 18180612
[TBL] [Abstract][Full Text] [Related]
10. Treatment of acute immune thrombocytopenic purpura.
Tarantino MD; Goldsmith G
Semin Hematol; 1998 Jan; 35(1 Suppl 1):28-35. PubMed ID: 9523747
[TBL] [Abstract][Full Text] [Related]
11. Recurrent immune thrombocytopenic purpura in children.
Jayabose S; Levendoglu-Tugal O; Ozkaynak MF; Sandoval C
Pediatr Hematol Oncol; 2006 Dec; 23(8):677-82. PubMed ID: 17065144
[TBL] [Abstract][Full Text] [Related]
12. Low rate of long-lasting remissions after successful treatment of immune thrombocytopenic purpura with rituximab.
Schweizer C; Reu FJ; Ho AD; Hensel M
Ann Hematol; 2007 Oct; 86(10):711-7. PubMed ID: 17622529
[TBL] [Abstract][Full Text] [Related]
13. The response to splenectomy in pediatric patients with idiopathic thrombocytopenic purpura who fail high-dose intravenous immune globulin.
Hemmila MR; Foley DS; Castle VP; Hirschl RB
J Pediatr Surg; 2000 Jun; 35(6):967-71; discussion 971-2. PubMed ID: 10873046
[TBL] [Abstract][Full Text] [Related]
14. Presence of Idiopathic Thrombocytopenic Purpura and autoimmune hemolytic anemia in the patients with common variable immunodeficiency.
Ramyar A; Aghamohammadi A; Moazzami K; Rezaei N; Yeganeh M; Cheraghi T; Pouladi N; Heydari G; Abolhassani H; Amirzargar AA; Parvaneh N; Moin M
Iran J Allergy Asthma Immunol; 2008 Sep; 7(3):169-75. PubMed ID: 18780952
[TBL] [Abstract][Full Text] [Related]
15. A multicenter prospective study on the treatment of chronic idiopathic thrombocytopenic purpura.
Dan K; Gomi S; Kuramoto A; Maekawa T; Nomura T
Int J Hematol; 1992 Jun; 55(3):287-92. PubMed ID: 1498319
[TBL] [Abstract][Full Text] [Related]
16. [Efficacy of various treatments in the management of idiopathic thrombocytopenic purpura in the adult].
Llamas P; Busto MJ; Díez JL; Cabrera R; Regidor C; Forés R; Sanjuán I; Briz M; Fernández MN
Sangre (Barc); 1995 Jun; 40(3):181-5. PubMed ID: 7570269
[TBL] [Abstract][Full Text] [Related]
17. Possible lower rate of chronic ITP after IVIG for acute childhood ITP an analysis from registry I of the Intercontinental Cooperative ITP Study Group (ICIS).
Tamminga R; Berchtold W; Bruin M; Buchanan GR; Kühne T
Br J Haematol; 2009 Jul; 146(2):180-4. PubMed ID: 19466971
[TBL] [Abstract][Full Text] [Related]
18. Management of adult idiopathic thrombocytopenic purpura.
Nakhoul IN; Kozuch P; Varma M
Clin Adv Hematol Oncol; 2006 Feb; 4(2):136-44, 153. PubMed ID: 16728922
[TBL] [Abstract][Full Text] [Related]
19. Rituximab in auto-immune haemolytic anaemia and immune thrombocytopenic purpura: a Belgian retrospective multicentric study.
Dierickx D; Verhoef G; Van Hoof A; Mineur P; Roest A; Triffet A; Kentos A; Pierre P; Boulet D; Bries G; Lê PQ; Janssens A; Delannoy A
J Intern Med; 2009 Nov; 266(5):484-91. PubMed ID: 19549092
[TBL] [Abstract][Full Text] [Related]
20. Role of intravenous immunoglobulin G in autoimmune hematologic disorders.
Blanchette VS; Kirby MA; Turner C
Semin Hematol; 1992 Jul; 29(3 Suppl 2):72-82. PubMed ID: 1509297
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]